KospicyKorean filings in English
Filings / NeopharmCO

Preliminary Operating Results (Fair Disclosure)

NeopharmCO · 영업(잠정)실적(공정공시)

8-KKOSDAQ · 092730 Filed 2026-11-09Korean original on DART

English form view 50% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Preliminary Operating Results (Fair Disclosure)

Results Period
Current Period Results2026-07-01~2026-09-30
Prior Period Results2026-04-01~2026-06-30
Prior-Year Same Period Results2025-07-01~2025-09-30
Current Period Cumulative Results2026-01-01~2026-09-30
Prior-Year Same Period Cumulative Results2025-01-01~2025-09-30
※ 당해 정보는 확정치가 아닌 잠정치로 결산 결과 등에 따라 변경될 수 있음.
1. Performance Details
Category (Unit: KRW m, %)Current Period ResultsPrior Period Resultsvs. Prior PeriodPrior-Year Same Period ResultsYoY
(26.3Q)(26.2Q)Change (%)Profit/loss turnaround(25.3Q)Change (%)Profit/loss turnaround
RevenueCurrent Results39,38343,571-9.6-32,19622.3-
Cumulative Results119,179---95,78624.4-
Operating IncomeCurrent Results10,0449,7892.6-6,76848.4-
Cumulative Results28,537---21,55932.4-
Income from continuing operations before income taxCurrent Results6,31910,990-42.5-8,499-25.7-
Cumulative Results28,513---23,82019.7-
Net IncomeCurrent Results4,9418,405-41.2-6,859-28.0-
Cumulative Results21,970---21,0624.3-
--------
2. Information ProvidedInformation Provider주식회사 네오팜
Information Recipient기관투자자 및 애널리스트, 언론사, 일반투자자 등
Information release date (scheduled)Ad Hoc Provision After Fair Disclosure
Information release time (scheduled)-
Event Name (Venue)-
3. ContactChief Disclosure Officer (Name)임우재 부문장
Chief Disclosure Officer (Phone)02-591-4523
Disclosure Officer (Name)남승하 매니저
Disclosure Officer (Phone)02-591-4523
Department Name경영지원본부
Department (Phone)02-591-4523
4. Other Matters Relevant to Investment Decisions- 상기 실적은 한국채택국제회계 기준(K-IFRS)에 따라 작성된 개별 기준 잠정영업실적입니다. - 2026년 1분기 종속회사 청산에 따라 당기 및 전기 실적은 개별 기준으로 작성되었으며, 비교 표시의 목적으로 전년동기 실적은 연결 기준으로 작성되었습니다. - 본 공시자료는 외부감사인의 검토를 받지 않은 내부결산자료이므로 향후 결산 및 외부감사인의 검토결과에 따라 변동될 수도 있습니다.
Related Disclosures-